MyEllevate
- Company typePrivate
- Founded-
- HeadquartersNewport Beach, United States
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
MyEllevate firmographics
Firmographics- Name
- MyEllevate
- Legal name
- MyEllevate
- Website
- https://myellevate.com
- Company type
- Private
- Operating status
- Operating
- Ownership category
- akta.pro rank
MyEllevate industry classification
Industry- Product category
- Aesthetic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Facial Plastic & Reconstructive Surgery (ENT) (HLAKAMAG)
- akta.pro secondary industry
- Cosmetic Dermatology (Aesthetic Injectables) (HLAKACAE)
Keywords
Where MyEllevate is headquartered
LocationHeadquarters
- HQ city
- Newport Beach
- HQ country
- United States
- HQ region
- North America
Markets served
MyEllevate business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations
Revenue model
- Surgical Kit Sales: MyEllevate generates revenue through the sale of single-use disposable surgical procedure kits to trained and registered providers. Kits are available in single, 5-kit, and 10-kit packages with volume discounts. The procedure takes approximately one hour to perform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Single MyEllevate Kit |
| Unit Pricing | Pay-as-you-go | 5-Kit Package |
| Unit Pricing | Pay-as-you-go | 10-Kit Package (Best Deal) |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
MyEllevate product offering
Product offeringCore offering
MyEllevate commercializes a minimally invasive facial rejuvenation procedure that uses its proprietary ICLED Surgical Suture System with light-guided Suturod technology. The company sells single-use disposable surgical kits containing the suture tools and templates to trained medical providers who perform the procedure on patients seeking neck and lower-face lift results without traditional open surgery.
Product overview
MyEllevate is a minimally invasive facial rejuvenation procedure portfolio built around the proprietary ICLED Surgical Suture System. The core offering includes the MyEllevate procedure, which uses light-guided Suturod technology to place a continuous permanent suture along the jawline for soft tissue elevation. The ICLED Surgical Suture System is sold as single-use disposable surgical kits containing precision tools, marking templates, and permanent braided polyester sutures. Results last five years or more, and the procedure can be performed alone or combined with energy-based skin tightening technologies.
Differentiator
Problem solved
Functional benefit
Products and services
- MyEllevate Surgical Procedure Kit A single-use disposable surgical kit featuring the proprietary ICLED Surgical Suture System and light-guided Suturod instruments, sold exclusively to trained MyEllevate surgeons who perform the minimally invasive neck and lower-face rejuvenation procedure on patients.
- MyEllevate Procedure (Facial Rejuvenation Treatment) The branded minimally invasive facial rejuvenation procedure performed by trained MyEllevate surgeons using the company's ICLED Surgical Suture System to suspend underlying facial tissues and redefine the jawline and neck for patients seeking less invasive alternatives to traditional facelift surgery.
Quantifiable outcome
- Results last 5+ years
- +3 more outcomes
Companies that use MyEllevate
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
MyEllevate technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
MyEllevate partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights5 records
MyEllevate competitors and assessment
Company assessmentDirect peers
- InMode: InMode offers FaceTite and AccuTite, which are minimally invasive radiofrequency-assisted facial contouring procedures that directly compete with MyEllevate's jawline contouring approach for similar plastic surgery and dermatology providers.
- Cynosure: Cynosure (a Hologic company) provides aesthetic energy-based devices used by plastic surgeons and dermatologists for facial rejuvenation, competing for the same provider accounts and patient procedure slots as MyEllevate.
- Cutera: Cutera sells energy-based aesthetic platforms (including facial contouring and skin tightening systems) into the same plastic surgeon and dermatologist customer base that MyEllevate targets with its suture-based procedure kits.
- Apyx Medical: Apyx Medical markets the Renuvion system for subdermal tissue coagulation and skin contraction during facial and body procedures, directly competing with MyEllevate's minimally invasive soft-tissue elevation approach in the same provider channel.
- Sciton: Sciton manufactures laser and light-based platforms used for facial rejuvenation and skin tightening, and explicitly references combination use with energy-based devices — a positioning that overlaps with MyEllevate's adjunctive use cases.
Broad incumbents
- AbbVie (Allergan Aesthetics): AbbVie's Allergan Aesthetics division sells facial injectables (Botox, fillers, Kybella) into the same plastic surgeon and dermatology channels, and competes for share-of-wallet against MyEllevate in lower-face rejuvenation consultations.
- Merz Aesthetics: Merz Aesthetics sells injectables, fillers, and energy-based devices (Ultherapy) used by plastic surgeons and dermatologists for facial rejuvenation, directly competing for provider mindshare and patient demand against MyEllevate.
- Galderma: Galderma offers a broad facial aesthetics portfolio (Restylane, Sculptra, Dysport) used by the same dermatology and plastic surgery providers who perform MyEllevate, and competes in patient consultations for jawline and lower-face rejuvenation.
- Solta Medical: Solta Medical (a Bausch Health company) markets Thermage and Clear+Brilliant for facial skin tightening and rejuvenation, competing in the broader minimally invasive facial aesthetics category where MyEllevate positions itself.
Emerging players
- Evolus: Evolus is a newer aesthetics company focused on facial injectable neurotoxins (Jeuveau) sold into the same aesthetic practice channel as MyEllevate, representing a focused competitor for the early-aging patient demographic.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
MyEllevate financial estimates
Financial estimateRevenue estimate
Valuation estimate
MyEllevate leadership team
Management profileNumber of profiles
Profiles1 record
MyEllevate funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MyEllevate M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MyEllevate
What does MyEllevate do?
MyEllevate commercializes a minimally invasive facial rejuvenation procedure that uses its proprietary ICLED Surgical Suture System with light-guided Suturod technology. The company sells single-use disposable surgical kits containing the suture tools and templates to trained medical providers who perform the procedure on patients seeking neck and lower-face lift results without traditional open surgery.
Is MyEllevate a public or private company?
MyEllevate is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MyEllevate founded?
MyEllevate was founded in -1.
Where is MyEllevate based?
MyEllevate is headquartered in Newport Beach, United States, in the North America region.
How does MyEllevate make money?
One revenue line is on record: surgical Kit Sales.
Who are MyEllevate's main competitors?
Direct peers on record are InMode, Cynosure, Cutera, Apyx Medical and Sciton. Broad incumbents are AbbVie (Allergan Aesthetics), Merz Aesthetics, Galderma and Solta Medical. Evolus is listed as an emerging player.
Does MyEllevate have an API?
No public API is recorded for MyEllevate.
What industry is MyEllevate in?
MyEllevate's product category is Aesthetic Medical Devices. Its primary akta.pro industry code is HLAKAMAG, Facial Plastic & Reconstructive Surgery (ENT), with a secondary code of HLAKACAE, Cosmetic Dermatology (Aesthetic Injectables). Its NAICS code is 339113 and its SIC code is 3842.